Very Long Term Follow up a Phase II Study of Post-Remission Subcutaneous (SC) Azacitidine (AZA) in Patients with AML Post-MDS or Higher-Risk (HR) MDS

Cherait, A; Braun, T; Bouabdallah, K; Caillot, D; Guerci, A; Raffoux, E; Marolleau, JP; Pautas, C; Banos, A; Himberlin, C; Taksin, AL; Pigneux, A; Thomas, X; Vey, N; Chevret, S; Dombret, H; Chermat, F; Ades, L; Gardin, C; Fenaux, P

BLOOD, 2020; 136 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索